
TriOncoFAP-GlyPro-MMAE is a малая молекула препарат conjugate (SMDC) targeting fibroblast activation protein (FAP) with an IC50 of 13 pmol/L. TriOncoFAP-GlyPro-MMAE combines a FAP-targeting лиганд (TriOnco), a cleavable glycine-proline linker, and a cytotoxic payload (MMAE).
TriOncoFAP-GlyPro-MMAE is a small molecule drug conjugate (SMDC) targeting fibroblast activation protein (FAP) with an IC50 of 13 pmol/L. TriOncoFAP-GlyPro-MMAE combines a FAP-targeting ligand (TriOnco), a cleavable glycine-proline linker, and a cytotoxic payload (MMAE).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.